Mechanics Bank Trust Department Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mechanics Bank Trust Department increased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 4.2% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,421 shares of the healthcare conglomerate’s stock after purchasing an additional 302 shares during the period. Mechanics Bank Trust Department’s holdings in UnitedHealth Group were worth $3,811,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of UNH. Advocacy Wealth Management Services LLC grew its stake in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. grew its stake in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares in the last quarter. Rise Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter worth about $38,000. Evolution Advisers Inc. acquired a new position in UnitedHealth Group in the first quarter valued at approximately $38,000. Finally, Cordant Inc. acquired a new position in UnitedHealth Group in the first quarter valued at approximately $45,000. 87.25% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $517.46 on Friday. The stock has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29. The stock’s 50 day moving average price is $530.11 and its 200 day moving average price is $512.45. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm’s revenue was up 12.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.70 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were issued a $1.65 dividend. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now directly owns 787,372 shares in the company, valued at approximately $420,669,238.44. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 139,051 shares of company stock worth $74,450,958. Corporate insiders own 0.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on UNH shares. BMO Capital Markets lifted their target price on UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. UBS Group lifted their target price on UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, July 21st. Sanford C. Bernstein downgraded UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Credit Suisse Group boosted their price objective on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.